Related references
Note: Only part of the references are listed.Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
Sinan Wang et al.
CLINICAL CANCER RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Michael S. Hofman et al.
LANCET (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells
Maryam Afsharzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89
Denis R. Beckford Vera et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Targeted and Reduction-Sensitive Cross-Linked PLGA Nanotherapeutics for Safer and Enhanced Chemotherapy of Malignant Melanoma
Xiuxiu Wang et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Boron agents for neutron capture therapy
Kuan Hu et al.
COORDINATION CHEMISTRY REVIEWS (2020)
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect
Jeroen A. C. M. Goos et al.
THERANOSTICS (2020)
PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities
Yajie Zhang et al.
NANOSCALE (2020)
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy
Sinan Wang et al.
MOLECULAR PHARMACEUTICS (2019)
On-Demand Biodegradable Boron Nitride Nanoparticles for Treating Triple Negative Breast Cancer with Boron Neutron Capture Therapy
Liping Li et al.
ACS NANO (2019)
Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Spencer C. Behr et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The efficiency of 18F labelling of a prostate specific membrane antigen ligand via strain-promoted azide-alkyne reaction: reaction speed versus hydrophilicity
Mengzhe Wang et al.
CHEMICAL COMMUNICATIONS (2018)
Sonochemical Synthesis of Small Boron Oxide Nanoparticles
Roshini Ramachandran et al.
INORGANIC CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Boron delivery agents for neutron capture therapy of cancer
Rolf F. Barth et al.
CANCER COMMUNICATIONS (2018)
111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues
Sangeeta R. Banerjee et al.
BIOMACROMOLECULES (2017)
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery
Yang Shi et al.
MACROMOLECULAR BIOSCIENCE (2017)
Redox-Responsive Disulfide Cross-Linked PLA-PEG Nanoparticles
Tiziana Fuoco et al.
MACROMOLECULES (2017)
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
Cindy J. Choy et al.
THERANOSTICS (2017)
Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies
Feng Chen et al.
CHEMISTRY OF MATERIALS (2017)
Hydrophobic boron compound-loaded poly(L-lactide-co-glycolide) nanoparticles for boron neutron capture therapy
Issei Takeuchi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo
Yaqin Zhu et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Microfluidic Synthesis of Nanomaterials for Biomedical Applications
Li-Li Li et al.
SMALL METHODS (2017)
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
Jessie R. Nedrow et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy
Zhongjian Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Boron Neutron Capture Therapy in the Treatment of Recurrent Laryngeal Cancer
Aaro Haapaniemi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Small-molecule PSMA ligands. Current state, SAR and perspectives
Alexey E. Machulkin et al.
JOURNAL OF DRUG TARGETING (2016)
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Current use of PSMA - PET in prostate cancer management
Tobias Maurer et al.
NATURE REVIEWS UROLOGY (2016)
Preparation of [68Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based 68Ge/68Ga generator
Raviteja Nanabala et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
Feng Chen et al.
ACS NANO (2015)
Silica Nanoparticles as Substrates for Chelator-free Labeling of Oxophilic Radioisotopes
Travis M. Shaffer et al.
NANO LETTERS (2015)
Design considerations for nanotherapeutics in oncology
Triantafyllos Stylianopoulos et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: A boron neutron capture therapy study
Ian Gifford et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2014)
Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model
Elisa M. Heber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
John A. Barrett et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Strategies for advancing cancer nanomedicine
Vikash P. Chauhan et al.
NATURE MATERIALS (2013)
Boron neutron capture in prostate cancer cells
Linda Yasui et al.
APPLIED RADIATION AND ISOTOPES (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan et al.
NATURE NANOTECHNOLOGY (2012)
Boron neutron capture therapy assisted by boron-conjugated nanoparticles
Shogo Sumitani et al.
POLYMER JOURNAL (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Synthesis of Size-Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single-Layer Microchannels
Minsoung Rhee et al.
ADVANCED MATERIALS (2011)
Fluorescent Nanorods and Nanospheres for Real-Time In Vivo Probing of Nanoparticle Shape-Dependent Tumor Penetration
Vikash P. Chauhan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles
Pedro M. Valencia et al.
BIOMATERIALS (2011)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Drug Uptake Systems in Liver and Kidney: A Historic Perspective
B. Hagenbuch
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma
Tadashi Nariai et al.
APPLIED RADIATION AND ISOTOPES (2009)
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
Shawn M. Hillier et al.
CANCER RESEARCH (2009)
A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
K. P. Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization
Cyril Barinka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Approach to formation of multifunctional polyester particles in controlled nanoscopic dimensions
Alice E. van der Ende et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Frank Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Estradiol loaded PLGA nanoparticles for oral administration:: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo
G. Mittal et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
Sven Perner et al.
HUMAN PATHOLOGY (2007)
Tissue disposition of 5-o-carboranyluracil - A novel agent for the boron neutron capture therapy of prostate cancer
RF Schinazi et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2004)
Natural history of early localized prostate cancer
JR Osborn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
